Results 21 to 30 of about 9,360,292 (409)

Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Rheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage.
A. Beaton   +24 more
semanticscholar   +1 more source

Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS–CoV‐2 Messenger RNA Vaccination

open access: yesArthritis & Rheumatology, 2021
To evaluate disease flare and postvaccination reactions (reactogenicity) in patients with rheumatic and musculoskeletal diseases (RMDs) following 2‐dose SARS–CoV‐2 messenger RNA (mRNA) vaccination.
C. Connolly   +9 more
semanticscholar   +1 more source

American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

open access: yesArthritis & Rheumatology, 2020
To provide guidance to rheumatology providers on the management of adult rheumatic disease in the context of the coronavirus disease 2019 (COVID‐19) pandemic.
T. Mikuls   +15 more
semanticscholar   +1 more source

Bridging the gap between science and indigenous cosmologies: Rheumatic Heart Disease Champions4Change [PDF]

open access: yesMicrobiology Australia, 2022
Australia has articulated a commitment to eliminate rheumatic heart disease (RHD) by 2031. Business as usual will not achieve this goal. Diverse sectors need to work together in implementing complementary strategies towards this ambitious target ...
Maida Stewart, Vicki Wade
doaj  

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer

open access: yesTechnology in Cancer Research & Treatment, 2022
Pancreatic cancer has the highest mortality rate of all major cancers, with a 5-year survival rate of about 10%. Early warning signs and symptoms of pancreatic cancer are vague or nonexistent, and most patients are diagnosed in Stage IV, when surgery is ...
Peng Dong MM   +12 more
doaj   +1 more source

Rheumatic disease and COVID-19: epidemiology and outcomes

open access: yesNature Reviews Rheumatology, 2020
Since the outset of the COVID-19 pandemic, numerous risk factors for severe disease have been identified. Whether patients with rheumatic diseases, especially those receiving DMARDs, are at an increased risk of SARS-CoV-2 infection or severe COVID-19 ...
K. Hyrich, P. Machado
semanticscholar   +1 more source

Cytokines as a predictor of progression to valvular disease in children with rheumatic fever [PDF]

open access: yes, 2006
The immunologic basis of rheumatic fever is well established. However the role of penicillin in the control of the rheumatic process and the prevention of development of rheumatic heart disease is poorly understood.Objectivethe objective of this study ...
Abul-fadl, Azza   +2 more
core   +1 more source

Treatment of rheumatoid arthritis and its outcomes in an aging society: a single-center cohort study in Japan from 2011 to 2020

open access: yesArthritis Research & Therapy, 2022
Background We conducted a single-center cohort study of rheumatoid arthritis (RA) patients from 2011 to 2020 to understand their real world treatment and outcomes, especially changes in physical function and quality of life (QOL) in elderly patients ...
Wataru Fukuda   +10 more
doaj   +1 more source

Determinants of COVID-19 disease severity in patients with underlying rheumatic disease

open access: yesClinical Rheumatology, 2020
Over the month of April, Spain has become the European country with more confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of Castile and León in Spain is one of the most affected by COVID-19 infection and the ...
C. S. Santos   +5 more
semanticscholar   +1 more source

Rheumatic Diseases in China [PDF]

open access: yesArthritis Research & Therapy, 2008
Abstract Introduction Epidemiological studies of rheumatic diseases have been conducted during the past 20 years in China. The aim of this study was to clarify prevalence rates of common rheumatic diseases in China.
Su Biao Chen   +7 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy